'Reinventing Patient Recruitment: Revolutionary Ideas for Clinical Trial Success' Is A Definitive Guide to Planning, Implementing, and Evaluating Recruitment Strategies and Campaigns Globally
Posted on: Wednesday, 13 December 2006, 06:01 CST
Research and Markets (http://www.researchandmarkets.com/reports/c46959) has announced the addition of Reinventing Patient Recruitment to their offering..
During the last five years, clinical research and development costs have risen exponentially without a proportionate increase in the number of new medications. While patient recruitment for clinical studies is only one component in the development of a new medicine or treatment, it is one of the most significant bottlenecks in the overall drug development process. Now it is imperative that industry leaders see beyond reactive measures and recognize that advancing their approach to patient recruitment is absolutely essential to advancing medicine and continuing the stability of their corporate brand across the globe.
"Reinventing Patient Recruitment: Revolutionary Ideas for Clinical Trial Success" is a definitive guide to planning, implementing, and evaluating recruitment strategies and campaigns globally. The combined experience of the authors provides a depth of perspective and boldness of innovative leadership to set the standards for future patient recruitment programs and practices. This book is a must-have for pharmaceutical, biotechnology, and medical device industry professionals concerned with enrolling for domestic and multinational clinical studies and remaining on time and on budget.
About the Author/Editor
Joan F. Bachenheimer and Bonnie A. Brescia are co-founders of BBK Worldwide, a full-service patient recruitment planning and implementation company for the clinical R&D segment of the pharmaceutical, biotechnology, and medical device industries. BBK Worldwide has helped to accelerate time to market for new medicines and treatments by successfully supporting hundreds of clinical studies in more than 60 countries, and in all major therapeutic areas. With more than 20 years of industry knowledge and experience to draw on, the authors have continually contributed ideas that accelerate and advance the clinical development cycle.
Content Outline:
Part I Getting Started: Putting the patient first
Planning your study: Think communication
Applied metrics: Project enrolments
Picking good sites
Budgeting and contracting for patient recruitment
Part II Development and Implementation: The importance of patient protections
Targeting the right patients
Site enrolment support
Metrics for evaluation and redeployment
Patient retention
Part III Going Global: The changing landscape of multinational clinical studies
Approaching ethics committees: Perspective and opportunity
Selecting countries, sites and tactics that work
Part IV Future Trends: Personalized medicine and biotechnology
Public perception and industry leadership
Appendices: Good Recruitment Practices
Clinical Research Coordinator Survey 2003
The Will and Why Survey 2001
The International Will and Why Survey 2004
Ethics Committee Survey 2005
Glossary
Index
For more information visit http://www.researchandmarkets.com/reports/c46959
Source: Business Wire
Related Articles
- 2008 Game Developer Salary Survey Reveals U.S. Game Industry Average Income of $79,000
- Alfred P. Sloan Foundation Awards Sloan Industry Studies Fellowships to Three Early Career Researchers
- Optium Expands ROADM Family With Development of the Industry's First Mixed Channel Plan WSS ROADM
- EarlySense Receives FDA Clearance for Its Contact-Free Patient's Clinical Status Monitor
- First Prostate Cancer Patients Treated in a Phase I Clinical Trial As Part of a Collaboration Between Generex Biotechnology and the Saint Savas Cancer Hospital
- Fifth Volume of the Japanese Patient Population Analysis and Epidemiological Survey Now Available
- General Satisfaction With Plan Benefits Found Among Patients Navigating Medicare Part D, According to Study By GfK Market Measures
- MEDecision's Patient Clinical Summary To Be Implemented By Memphis Managed Care Corporation
- First Patient Enrolled in SONOMA Post-Market Approval Study of Boston Scientific NexStent(R) Carotid Stent System and FilterWire EZ(TM) Embolic Protection Device
- The Fabricated Metal Parts Manufacturing Industry in the US Generates $200 Billion a Year
User Comments (0)

RSS Feeds